The North America Biopreservation Market was valued at $1764.2 Million in 2024 and projected to reach to $2852.9 Million by 2029, representing a compound annual growth rate of 10.1%. North America's biopreservation market is poised for sustained expansion, driven by increasing investments in cell and gene therapy research, growing demand for organ transplantation solutions, and the proliferation of biobanking facilities across the United States and Canada.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America commands the largest share of the global biopreservation market, driven by advanced healthcare infrastructure, substantial R&D investments, and early adoption of cutting-edge preservation technologies across the region.
The region is a global epicenter for regenerative medicine and cell therapy development, with numerous clinical trials and FDA-approved therapies creating sustained demand for sophisticated biopreservation solutions.
North America's stringent regulatory standards and established guidelines from the FDA and Health Canada ensure high-quality biopreservation practices, attracting investment and fostering market confidence among stakeholders.
With a 10.1% CAGR from 2024 to 2029, North America's biopreservation market is expanding faster than the global average of 9.8%, reflecting accelerating adoption in clinical and research applications.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | BIOPRESERVATION EQUIPMENT (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.8% from 2024 to 2029 |
| Largest Segment | BIOPRESERVATION MEDIA (Product) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 7.1 (2029) |
| Segments Covered | Product, Type, Biospecimen, Application, End User, Transplant Type |
6 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| US | USD 1234 Million |
| Canada | USD 110 Million |
North America's biopreservation market was valued at $1,764.2 million in 2024 and is expected to reach $2,852.9 million by 2029.
North America's biopreservation market is projected to grow at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2029.
North America's biopreservation market growth is driven by advances in regenerative medicine, increased cell therapy adoption, robust biotech funding, and stringent regulatory compliance requirements.
North America's biopreservation market is dominated by applications in stem cell research, organ transplantation, cell therapy manufacturing, and personalized medicine initiatives.
North America's biopreservation market grows at 10.1% CAGR, slightly outpacing the global market's 9.8% CAGR, reflecting the region's advanced healthcare infrastructure and research investment.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are:
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.
The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.
Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.
MarketsandMarkets offers the following customizations for this market report:
Full forecast, segment splits, and company analysis for all Biopreservation Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report